101 related articles for article (PubMed ID: 25759017)
1. The pre-BCR to the rescue: therapeutic targeting of pre-B cell ALL.
Trimarchi T; Aifantis I
Cancer Cell; 2015 Mar; 27(3):321-3. PubMed ID: 25759017
[TBL] [Abstract][Full Text] [Related]
2. Pre-B-cell Receptor Signaling Is a Therapeutic Target in Pre-B ALL.
Cancer Discov; 2015 May; 5(5):OF15. PubMed ID: 25790981
[No Abstract] [Full Text] [Related]
3. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.
Geng H; Hurtz C; Lenz KB; Chen Z; Baumjohann D; Thompson S; Goloviznina NA; Chen WY; Huan J; LaTocha D; Ballabio E; Xiao G; Lee JW; Deucher A; Qi Z; Park E; Huang C; Nahar R; Kweon SM; Shojaee S; Chan LN; Yu J; Kornblau SM; Bijl JJ; Ye BH; Ansel KM; Paietta E; Melnick A; Hunger SP; Kurre P; Tyner JW; Loh ML; Roeder RG; Druker BJ; Burger JA; Milne TA; Chang BH; Müschen M
Cancer Cell; 2015 Mar; 27(3):409-25. PubMed ID: 25759025
[TBL] [Abstract][Full Text] [Related]
4. Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.
Müschen M
Blood; 2015 Jun; 125(24):3688-93. PubMed ID: 25878119
[TBL] [Abstract][Full Text] [Related]
5. ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway.
Hiratsuka T; Takei Y; Ohmori R; Imai Y; Ozeki M; Tamaki K; Haga H; Nakamura T; Tsuruyama T
Oncogene; 2016 Jun; 35(25):3227-38. PubMed ID: 26522721
[TBL] [Abstract][Full Text] [Related]
6. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.
Nahar R; Ramezani-Rad P; Mossner M; Duy C; Cerchietti L; Geng H; Dovat S; Jumaa H; Ye BH; Melnick A; Müschen M
Blood; 2011 Oct; 118(15):4174-8. PubMed ID: 21856866
[TBL] [Abstract][Full Text] [Related]
7. Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.
Erasmus MF; Matlawska-Wasowska K; Kinjyo I; Mahajan A; Winter SS; Xu L; Horowitz M; Lidke DS; Wilson BS
Sci Signal; 2016 Nov; 9(456):ra116. PubMed ID: 27899526
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.
Fidanza M; Seif AE; DeMicco A; Rolf N; Jo S; Yin B; Li Y; Barrett DM; Duque-Afonso J; Cleary ML; Bassing CH; Grupp SA; Reid GS
Leukemia; 2016 Oct; 30(10):2116-2119. PubMed ID: 27220664
[No Abstract] [Full Text] [Related]
9. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
[TBL] [Abstract][Full Text] [Related]
10. BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint.
Swaminathan S; Duy C; Müschen M
Trends Immunol; 2014 Mar; 35(3):131-7. PubMed ID: 24332591
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
Feldhahn N; Henke N; Melchior K; Duy C; Soh BN; Klein F; von Levetzow G; Giebel B; Li A; Hofmann WK; Jumaa H; Müschen M
J Exp Med; 2007 May; 204(5):1157-66. PubMed ID: 17485517
[TBL] [Abstract][Full Text] [Related]
12. Science Signaling Podcast for 29 November 2016: Pre-B cell receptor signaling in leukemia.
Wilson BS; VanHook AM
Sci Signal; 2016 Nov; 9(456):c23. PubMed ID: 27899524
[TBL] [Abstract][Full Text] [Related]
13. PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.
Xue K; Song J; Yang Y; Li Z; Wu C; Jin J; Li W
Mol Immunol; 2016 May; 73():1-9. PubMed ID: 27016671
[TBL] [Abstract][Full Text] [Related]
14. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Williams RT; Sherr CJ
Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
[TBL] [Abstract][Full Text] [Related]
15. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
Deucher AM; Qi Z; Yu J; George TI; Etzell JE
Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
[TBL] [Abstract][Full Text] [Related]
16. RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.
Bednarski JJ; Pandey R; Schulte E; White LS; Chen BR; Sandoval GJ; Kohyama M; Haldar M; Nickless A; Trott A; Cheng G; Murphy KM; Bassing CH; Payton JE; Sleckman BP
J Exp Med; 2016 Feb; 213(2):209-23. PubMed ID: 26834154
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
Kasai S; Furuichi Y; Ando N; Kagami K; Abe M; Nakane T; Goi K; Inukai T; Saitoh S; Ohno S; Okazaki S; Nagano O; Saya H; Sugita K
Cell Death Dis; 2017 Jun; 8(6):e2857. PubMed ID: 28569787
[TBL] [Abstract][Full Text] [Related]
18. Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia.
Vázquez-Franco JE; Reyes-Maldonado E; Vela-Ojeda J; Domínguez-López ML; Lezama RA
Leuk Res; 2012 Jul; 36(7):862-7. PubMed ID: 22591684
[TBL] [Abstract][Full Text] [Related]
19. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.
Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M
Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957
[TBL] [Abstract][Full Text] [Related]
20. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
Duque-Afonso J; Smith KS; Cleary ML
PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
